Vivoryon Therapeutics
05Y.F
#10681
Rank
A$36.61 M
Marketcap
A$1.24
Share price
-1.33%
Change (1 day)
-57.03%
Change (1 year)

Earnings for Vivoryon Therapeutics (05Y.F)

Earnings in 2025: -A$15.43 Million

According to Vivoryon Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$15.43 Million, an increase over its 2024 earnings that were of -A$31.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vivoryon Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025-A$15.43 Million-51.41%
2024-A$31.76 Million-32.25%
2023-A$46.87 Million3.86%
2022-A$45.13 Million119.73%
2021-A$20.54 Million-31.83%
2020-A$30.13 Million131.72%
2019-A$13.01 Million-0.99%
2018-A$13.14 Million-19.03%
2017-A$16.22 Million-25.18%
2016-A$21.68 Million-1.05%
2015-A$21.91 Million6.16%
2014-A$20.64 Million3.23%
2013-A$19.99 Million-6.3%
2012-A$21.34 Million-22.35%
2011-A$27.48 Million